This combination tablet is indicated for the treatment of Parkinson's disease and syndrome. It is useful in relieving many of the symptoms of parkinsonism, particularly rigidity and bradykinesia. This tablet is frequently helpful in the management of tremor, dysphagia, sialorrhea and postural instability associated with Parkinson's disease and syndrome. Levodopa plus carbidopa before physiotherapy increases motor recovery after stroke.
* রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Levodopa, the metabolic precursor of dopamine, crosses the blood-brain barrier and is converted to dopamine in the brain. Carbidopa is a dopa decarboxylase (DDC) inhibitor which reduces the peripheral metabolism of Levodopa to dopamine, and thus, more Levodopa becomes available to the brain.
Levodopa, the metabolic precursor of dopamine, crosses the blood-brain barrier and is converted to dopamine in the brain. Carbidopa is a dopa decarboxylase (DDC) inhibitor which reduces the peripheral metabolism of Levodopa to dopamine, and thus, more Levodopa becomes available to the brain.
Levodopa, the metabolic precursor of dopamine, crosses the blood-brain barrier and is converted to dopamine in the brain. Carbidopa is a dopa decarboxylase (DDC) inhibitor which reduces the peripheral metabolism of Levodopa to dopamine, and thus, more Levodopa becomes available to the brain.
Levodopa, the metabolic precursor of dopamine, crosses the blood-brain barrier and is converted to dopamine in the brain. Carbidopa is a dopa decarboxylase (DDC) inhibitor which reduces the peripheral metabolism of Levodopa to dopamine, and thus, more Levodopa becomes available to the brain.
Levodopa, the metabolic precursor of dopamine, crosses the blood-brain barrier and is converted to dopamine in the brain. Carbidopa is a dopa decarboxylase (DDC) inhibitor which reduces the peripheral metabolism of Levodopa to dopamine, and thus, more Levodopa becomes available to the brain.
Levodopa, the metabolic precursor of dopamine, crosses the blood-brain barrier and is converted to dopamine in the brain. Carbidopa is a dopa decarboxylase (DDC) inhibitor which reduces the peripheral metabolism of Levodopa to dopamine, and thus, more Levodopa becomes available to the brain.
Antiparkinson drugs
Store in a cool and dry place, protected from light.
Levodopa, the metabolic precursor of dopamine, crosses the blood-brain barrier and is converted to dopamine in the brain. Carbidopa is a dopa decarboxylase (DDC) inhibitor which reduces the peripheral metabolism of Levodopa to dopamine, and thus, more Levodopa becomes available to the brain.
ACI Limited
Unit Price : ৳ 6.50
ACI Limited
Unit Price : ৳ 10.00
Drug International Ltd.
Unit Price : ৳ 8.00
Drug International Ltd.
Unit Price : ৳ 7.00
UniMed UniHealth Pharmaceuticals Ltd.
Unit Price : ৳ 7.00
UniMed UniHealth Pharmaceuticals Ltd.
Unit Price : ৳ 10.00
Opsonin Pharma Ltd.
Unit Price : ৳ 7.00
Opsonin Pharma Ltd.
Unit Price : ৳ 10.00
Albion Laboratories Limited
Unit Price : ৳ 11.80
Albion Laboratories Limited
Unit Price : ৳ 7.00
Healthcare Pharmaceuticals Ltd.
Unit Price : ৳ 8.00
Healthcare Pharmaceuticals Ltd.
Unit Price : ৳ 10.00
Healthcare Pharmaceuticals Ltd.
Unit Price : ৳ 7.00
Square Pharmaceuticals PLC
Unit Price : ৳ 7.00
Square Pharmaceuticals PLC
Unit Price : ৳ 10.00
Popular Pharmaceuticals Ltd.
Unit Price : ৳ 7.00
ACME Laboratories Ltd.
Unit Price : ৳ 4.01
ACME Laboratories Ltd.
Unit Price : ৳ 7.52
General Pharmaceuticals Ltd.
Unit Price : ৳ 7.00
General Pharmaceuticals Ltd.
Unit Price : ৳ 10.00
Incepta Pharmaceuticals Ltd.
Unit Price : ৳ 10.00
Incepta Pharmaceuticals Ltd.
Unit Price : ৳ 8.00
Incepta Pharmaceuticals Ltd.
Unit Price : ৳ 7.02
Sun Pharmaceutical (Bangladesh) Ltd.
Unit Price : ৳ 7.02
Sun Pharmaceutical (Bangladesh) Ltd.
Unit Price : ৳ 10.03